Viewing Study NCT04833296



Ignite Creation Date: 2024-05-06 @ 3:59 PM
Last Modification Date: 2024-10-26 @ 2:01 PM
Study NCT ID: NCT04833296
Status: UNKNOWN
Last Update Posted: 2021-04-06
First Post: 2021-03-31

Brief Title: Ropivacaine Use in Interscalene Block What is the Minimal Effective Analgesic Concentration MEAC 90
Sponsor: Healthpoint Hospital
Organization: Healthpoint Hospital

Study Overview

Official Title: Ropivacaine Use in Interscalene Block What is the Minimal Effective Analgesic Concentration MEAC 90
Status: UNKNOWN
Status Verified Date: 2021-04
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aim to calculate the minimal effective ropivacaine concentration required achieve successful analgesic interscalene block in 90 of patients MEAC90
Detailed Description: Before induction of general anesthesia all patients will receive interscalene block using 15ml of ropivacaine which concentration will be based on the response of the previous patient
Based on biased-coin design up-down sequential method if patient has pain free recovery a successful block the next patient will be randomized to receive either the same ropivacaine concentration or a concentration 001 wv less However if he has an unsuccessful block the next patient will receive a concentration 001 wv higher
Patients with pain free recovery will be considered to have positive response
Patients responses will be analyzed to calculate the MEAC90

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None